3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Urinary Bladder Neoplasms
2
Respiratory Aspiration
1
Recurrence
1
Pulmonary Atelectasis
1
Pneumothorax
1
Pleural Neoplasms
1
Pleural Effusion, Malignant
1
Pleural Diseases
1
Pericardial Effusion
1
Pancreatic Neoplasms
1
Pain, Postoperative
1
Neoplastic Cells, Circulating
1
Neoplasm Metastasis
1
Mesothelioma, Malignant
1
Melanoma
1
Lung Diseases
1
Hyperparathyroidism
1
Hemothorax
1
Empyema, Pleural
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Breast Cancer Female
1
Airway Obstruction
1
Interventions
Tamoxifen
2
pembrolizumab
1
Tretinoin
1
Tocopherols
1
Standard of Care
1
Pentoxifylline
1
Passive Cutaneous Anaphylaxis
1
Mifepristone
1
Metformin
1
Isotretinoin
1
Culture Techniques
1
Cannabidiol
1
Atorvastatin
1
Anesthesia, General
1
Anesthesia, Conduction
1
Analgesia, Patient-Controlled
1
Alitretinoin
1
Acceptance and Commitment Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Breast Cancer Female
×
Anesthesia, General
×
Clear all
NCT03779685
2020-08-05
GENEXAN
Azienda Ospedaliera San Gerardo di Monza
Phase NA
Unknown
100 enrolled